Owkin and Tribun Health Launch Strategic Partnership to Accelerate Access to AI Solutions for Diagnosis and Pharma Research

1 year ago

PARIS, FRANCE / ACCESSWIRE / September 11, 2023 / Owkin and Tribun Health announce a strategic partnership to advance the…

Visionary Foundation 2023 Impact Statement on Surgical Mission

1 year ago

2023 Impact Statement of the Honduras Surgical Eye MissionWASHINGTON, DC / ACCESSWIRE / September 11, 2023 / The Visionary Foundation…

Bausch Health’s Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA(R)

1 year ago

LAVAL, QC / ACCESSWIRE / September 11, 2023 / Bausch + Lomb Corporation ("Bausch + Lomb") (NYSE/TSX:BLCO), a subsidiary of…

Nutriband Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

1 year ago

Second quarter 2023 revenues increased 48% compared to second quarter 2022ORLANDO, FL / ACCESSWIRE / September 11, 2023 / Nutriband…

Nemaura Medical Completes 100 Patient Study for sugarBEAT® 24-hour Wear and Reports Interim Results

1 year ago

LOUGHBOROUGH, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company…

Palisade Bio Appoints GI Clinical Expert and Biotech Entrepreneur Mitchell Jones, M.D., Ph.D. as Chief Medical Officer

1 year ago

Announces Awarding of Inducement Grant to New Chief Medical Officer Carlsbad, CA, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq:…

CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conference

1 year ago

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life…

Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)

1 year ago

Overall response rate (ORR) greater than 50% across three assessment criteria Median duration of tovorafenib treatment of 15.8 months as…

Avertix to Present at Two Upcoming Investor Conferences in September 2023

1 year ago

EATONTOWN, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. (“Avertix” or the “Company”), a company focused on improving…